<DOC>
	<DOC>NCT00662519</DOC>
	<brief_summary>The primary purpose of this study is to find out if giving a 12 week course of Neulasta (Pegylated granulocyte colony stimulating factor (GCSF)) to people with type 1 diabetes (T1D) is safe. The secondary purpose of this research study is to determin if giving GCSF to patients with T1D changes the immune system or preserves insulin production.</brief_summary>
	<brief_title>Neulasta in Type 1 Diabetes</brief_title>
	<detailed_description>As a participant in this study the following will happen: Blood test, Mixed meal Tolerance Test (MMT) to find out how much C-peptide is being produced, Human Leukocyte Antigen (HLA) test, Hemoglobin A1C (HbA1c) test for overall blood sugar control, and randomized to either receive the 12 week course of Neulasta (Pegylated granulocyte colony stimulating factor (GCSF)) or a placebo (no medication).</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 1</mesh_term>
	<mesh_term>Lenograstim</mesh_term>
	<criteria>Must be &gt; 12 years old and have a confirmed diagnosis of "recent onset T1D" as defined by: T1D for &lt; 6 months, Stimulated Cpeptide â‰¥ 0.2 pmol/ml Presence of at least one diabetesrelated autoantibody (e.g., GAD, IA2, IAA, ICA) Normal screening values for CBC Willing to comply with intensive diabetes management No history of allergy to GCSF Females having reproductive potential must be willing to avoid pregnancy and have a negative pregnancy test Known hypersensitivity to E.Coliderived proteins, pegfilgrastim, Filgrastim, or any other component of the product Chronic use of steroids or other immunosuppressive agents Active infection Inability to maintain intensive diabetes management Pregnancy History of malignancy Currently participating in another type 1 diabetes treatment study. Use of noninsulin pharmaceuticals that affect glycemic control</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>